MedTrace Logo

A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B

NCT05343065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2023-03-17

No results posted yet for this study

Summary

This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor.

Conditions

Interventions

DEVICE

BlueStar 10

An app that coaches individuals with diabetes and supports insulin-dosing based on continuous glucose monitor data

Sponsors & Collaborators

  • Welldoc

    lead INDUSTRY

Principal Investigators

  • Jean Park · Medstar Health Research Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-05
Primary Completion
2022-12-20
Completion
2022-12-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05343065 on ClinicalTrials.gov